Lipidomics of host-pathogen interactions

FEBS Letters

Volumn 580, Issue 23, 2006, Pages 5541-5551

  Wenk, Markus R ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Host pathogen; Lipidomics; Mass spectrometry; Membrane traffic

Indexed keywords

LIPID;

BACTERIUM; CYTOLOGY; HOMEOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LIPID METABOLISM; MEMBRANE; MOLECULAR BIOLOGY; MYCOBACTERIUM; NONHUMAN; PARASITE; PATHOGENESIS; PLASMODIUM; PRIORITY JOURNAL; SALMONELLA; SHORT SURVEY; TOXOPLASMA; VIRUS;

ANIMALS; DISEASE; HOST-PARASITE RELATIONS; HUMANS; LIPID METABOLISM; MEMBRANE FUSION; MICROARRAY ANALYSIS;

EUKARYOTA;

EID: 33749051854     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.07.007     Document Type: Short Survey

References (137)

1. Heung L.J., Luberto C., and Del Poeta M. Role of sphingolipids in microbial pathogenesis. Infect. Immun. 74 (2006) 28-39
2. van der Kleij D., and Yazdanbakhsh M. Control of inflammatory diseases by pathogens: lipids and the immune system. Eur. J. Immunol. 33 (2003) 2953-2963
3. Fahy E., Subramaniam S., Brown H.A., Glass C.K., Merrill Jr. A.H., Murphy R.C., Raetz C.R., Russell D.W., Seyama Y., Shaw W., Shimizu T., Spener F., van M.G., VanNieuwenhze M.S., White S.H., Witztum J.L., and Dennis E.A. A comprehensive classification system for lipids. J. Lipid Res. 46 (2005) 839-861
4. Serhan C.N., and Savill J. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6 (2005) 1191-1197
5. Kitabwalla M., Villinger F., Akeefe H., Liao Z., Mayne A.E., Gargano L., Conner A.P., Maltais J.A., Kunas G., Hildreth J.E., Ansari A.A., and Bellotti M. Enhancement of cell mediated immune responses using lipid depleted lentivirus as immunogen: a novel approach for inducing recognition of new viral epitopes. Vaccine 23 (2005) 4666-4677
6. Wilson W.H., Schroeder D.C., Allen M.J., Holden M.T., Parkhill J., Barrell B.G., Churcher C., Hamlin N., Mungall K., Norbertczak H., Quail M.A., Price C., Rabbinowitsch E., Walker D., Craigon M., Roy D., and Ghazal P. Complete genome sequence and lytic phase transcription profile of a Coccolithovirus. Science 309 (2005) 1090-1092
7. Cluett E.B., and Machamer C.E. The envelope of vaccinia virus reveals an unusual phospholipid in Golgi complex membranes. J. Cell Sci. 109 Pt 8 (1996) 2121-2131
8. Brugger B., Glass B., Haberkant P., Leibrecht I., Wieland F.T., and Krausslich H.G. The HIV lipidome: a raft with an unusual composition. Proc. Natl. Acad. Sci. USA 103 (2006) 2641-2646
9. Lehmann M.J., Sherer N.M., Marks C.B., Pypaert M., and Mothes W. Actin- and myosin-driven movement of viruses along filopodia precedes their entry into cells. J. Cell Biol. 170 (2005) 317-325
10. Cheng Z.J., Deep S.R., Marks D.L., and Pagano R.E. Membrane microdomains, caveolae, and caveolar endocytosis of sphingolipids (Review). Mol. Membr. Biol. 23 (2006) 101-110
11. Chazal N., and Gerlier D. Virus entry, assembly, budding, and membrane rafts. Microbiol. Mol. Biol. Rev. 67 (2003) 226-237
12. Su A.I., Pezacki J.P., Wodicka L., Brideau A.D., Supekova L., Thimme R., Wieland S., Bukh J., Purcell R.H., Schultz P.G., and Chisari F.V. Genomic analysis of the host response to hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 99 (2002) 15669-15674
13. Le B.I., Luyet P.P., Pons V., Ferguson C., Emans N., Petiot A., Mayran N., Demaurex N., Faure J., Sadoul R., Parton R.G., and Gruenberg J. Endosome-to-cytosol transport of viral nucleocapsids. Nat. Cell. Biol. 7 (2005) 653-664
14. Ahola T., Lampio A., Auvinen P., and Kaariainen L. Semliki Forest virus mRNA capping enzyme requires association with anionic membrane phospholipids for activity. EMBO J. 18 (1999) 3164-3172
15. Kapadia S.B., and Chisari F.V. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc. Natl. Acad. Sci. USA 102 (2005) 2561-2566
16. Aloia R.C., Tian H., and Jensen F.C. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl. Acad. Sci. USA 90 (1993) 5181-5185
17. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gordon S.V., Eiglmeier K., Gas S., Barry III C.E., Tekaia F., Badcock K., Basham D., Brown D., Chillingworth T., Connor R., Davies R., Devlin K., Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K., Krogh A., McLean J., Moule S., Murphy L., Oliver K., Osborne J., Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton J., Squares R., Squares S., Sulston J.E., Taylor K., Whitehead S., and Barrell B.G. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 (1998) 537-544
18. Brennan P.J. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinb) 83 (2003) 91-97
19. Sulzenbacher G., Canaan S., Bordat Y., Neyrolles O., Stadthagen G., Roig-Zamboni V., Rauzier J., Maurin D., Laval F., Daffe M., Cambillau C., Gicquel B., Bourne Y., and Jackson M. LppX is a lipoprotein required for the translocation of phthiocerol dimycocerosates to the surface of Mycobacterium tuberculosis. EMBO J. 25 (2006) 1436-1444
20. Patel J.C., Rossanese O.W., and Galan J.E. The functional interface between Salmonella and its host cell: opportunities for therapeutic intervention. Trends Pharmacol. Sci. 26 (2005) 564-570
21. Finlay B.B., and McFadden G. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124 (2006) 767-782
22. Raetz C.R., and Whitfield C. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71 (2002) 635-700
23. Gilchrist M., Thorsson V., Li B., Rust A.G., Korb M., Kennedy K., Hai T., Bolouri H., and Aderem A. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441 (2006) 173-178
24. Murphy R.C., Raetz C.R., Reynolds C.M., and Barkley R.M. Mass spectrometry advances in lipidomica: collision-induced decomposition of Kdo2-lipid A. Prostaglandins Other Lipid Mediat. 77 (2005) 131-140
25. Mota L.J., Sorg I., and Cornelis G.R. Type III secretion: the bacteria-eukaryotic cell express. FEMS Microbiol. Lett. 252 (2005) 1-10
26. Schroder G., and Dehio C. Virulence-associated type IV secretion systems of Bartonella. Trends Microbiol. 13 (2005) 336-342
27. Rhoades E., Hsu F., Torrelles J.B., Turk J., Chatterjee D., and Russell D.G. Identification and macrophage-activating activity of glycolipids released from intracellular Mycobacterium bovis BCG. Mol. Microbiol. 48 (2003) 875-888
28. Andrade L.O., and Andrews N.W. The Trypanosoma cruzi-host-cell interplay: location, invasion, retention. Nat. Rev. Microbiol. 3 (2005) 819-823
29. Hernandez L.D., Hueffer K., Wenk M.R., and Galan J.E. Salmonella modulates vesicular traffic by altering phosphoinositide metabolism. Science 304 (2004) 1805-1807
30. Vergne I., Fratti R.A., Hill P.J., Chua J., Belisle J., and Deretic V. Mycobacterium tuberculosis phagosome maturation arrest: mycobacterial phosphatidylinositol analog phosphatidylinositol mannoside stimulates early endosomal fusion. Mol. Biol. Cell 15 (2004) 751-760
31. Munoz-Elias E.J., and McKinney J.D. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat. Med. 11 (2005) 638-644
32. Luo M., Fadeev E.A., and Groves J.T. Mycobactin-mediated iron acquisition within macrophages. Nat. Chem. Biol. 1 (2005) 149-153
33. Krithika R., Marathe U., Saxena P., Ansari M.Z., Mohanty D., and Gokhale R.S. A genetic locus required for iron acquisition in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 103 (2006) 2069-2074
34. Sohlenkamp C., Lopez-Lara I.M., and Geiger O. Biosynthesis of phosphatidylcholine in bacteria. Prog. Lipid Res. 42 (2003) 115-162
35. Rungruang T., Kaneko O., Murakami Y., Tsuboi T., Hamamoto H., Akimitsu N., Sekimizu K., Kinoshita T., and Torii M. Erythrocyte surface glycosylphosphatidyl inositol anchored receptor for the malaria parasite. Mol. Biochem. Parasitol. 140 (2005) 13-21
36. Murphy S.C., Hiller N.L., Harrison T., Lomasney J.W., Mohandas N., and Haldar K. Lipid rafts and malaria parasite infection of erythrocytes (Review). Mol. Membr. Biol. 23 (2006) 81-88
37. Grimwood J., and Smith J.E. Toxoplasma gondii: the role of parasite surface and secreted proteins in host cell invasion. Int. J. Parasitol. 26 (1996) 169-173
38. Coppens I., and Joiner K.A. Host but not parasite cholesterol controls Toxoplasma cell entry by modulating organelle discharge. Mol. Biol. Cell 14 (2003) 3804-3820
39. Coppens I., and Vielemeyer O. Insights into unique physiological features of neutral lipids in Apicomplexa: from storage to potential mediation in parasite metabolic activities. Int. J. Parasitol. 35 (2005) 597-615
40. Coppens I., Sinai A.P., and Joiner K.A. Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition. J. Cell Biol. 149 (2000) 167-180
41. Beckman M. Cell biology. Great balls of fat. Science 311 (2006) 1232-1234
42. Waltermann M., and Steinbuchel A. Neutral lipid bodies in prokaryotes: recent insights into structure, formation, and relationship to eukaryotic lipid depots. J. Bacteriol. 187 (2005) 3607-3619
43. Charron A.J., and Sibley L.D. Host cells: mobilizable lipid resources for the intracellular parasite Toxoplasma gondii. J. Cell Sci. 115 (2002) 3049-3059
44. Garton N.J., Christensen H., Minnikin D.E., Adegbola R.A., and Barer M.R. Intracellular lipophilic inclusions of mycobacteria in vitro and in sputum. Microbiology 148 (2002) 2951-2958
45. Blum J.J., and Ginsburg H. Absence of alpha-ketoglutarate dehydrogenase activity and presence of CO2-fixing activity in Plasmodium falciparum grown in vitro in human erythrocytes. J. Protozool. 1 (1984) 167-169
46. van Dooren G.G., Stimmler L.M., and McFadden G.I. Metabolic maps and functions of the Plasmodium mitochondrion. FEMS Microbiol. Rev. 30 (2006) 596-630
47. Wenk M.R. The emerging field of lipidomics. Nat. Rev. Drug Discov. 4 (2005) 594-610
48. Sonda S., and Hehl A.B. Lipid biology of Apicomplexa: perspectives for new drug targets, particularly for Toxoplasma gondii. Trends Parasitol. 22 (2006) 41-47
49. Stegmann T., Doms R.W., and Helenius A. Protein-mediated membrane fusion. Annu. Rev. Biophys. Biophys. Chem. 18 (1989) 187-211
50. Botelho R.J., Teruel M., Dierckman R., Anderson R., Wells A., York J.D., Meyer T., and Grinstein S. Localized biphasic changes in phosphatidylinositol-4, 5-bisphosphate at sites of phagocytosis. J. Cell Biol. 151 (2000) 1353-1368
51. Nguyen L., and Pieters J. The Trojan horse: survival tactics of pathogenic mycobacteria in macrophages. Trends Cell Biol. 15 (2005) 269-276
52. Huckriede A., Bungener L., Stegmann T., Daemen T., Medema J., Palache A.M., and Wilschut J. The virosome concept for influenza vaccines. Vaccine 23 Suppl 1 (2005) S26-S38
53. Mastrobattista E., van der Aa M.A., Hennink W.E., and Crommelin D.J. Artificial viruses: a nanotechnological approach to gene delivery. Nat. Rev. Drug. Discov. 5 (2006) 115-121
54. Balla T., and Varnai P. Visualizing cellular phosphoinositide pools with GFP-fused protein-modules. Sci. STKE 2002 (2002) L3
55. Moody D.B., and Porcelli S.A. Intracellular pathways of CD1 antigen presentation. Nat. Rev. Immunol. 3 (2003) 11-22
56. Akira S., and Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 4 (2004) 499-511
57. Inohara N., and Nunez G. ML - a conserved domain involved in innate immunity and lipid metabolism. Trends Biochem. Sci. 27 (2002) 219-221
58. Kang S.J., and Cresswell P. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat. Immunol. 5 (2004) 175-181
59. Raulin J. Human immunodeficiency virus and host cell lipids. Interesting pathways in research for a new HIV therapy. Prog. Lipid Res. 41 (2002) 27-65
60. Grunewald T., Burmester G.R., Schuler-Maue W., Hiepe F., and Buttgereit F. Antiphospholipid antibodies and CD5+ B cells in HIV infection. Clin. Exp. Immunol. 115 (1999) 464-471
61. Haynes B.F., Fleming J., St Clair E.W., Katinger H., Stiegler G., Kunert R., Robinson J., Scearce R.M., Plonk K., Staats H.F., Ortel T.L., Liao H.X., and Alam S.M. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 308 (2005) 1906-1908
62. Kanter J.L., Narayana S., Ho P.P., Catz I., Warren K.G., Sobel R.A., Steinman L., and Robinson W.H. Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat. Med. 12 (2006) 138-143
63. Marai I., Tincani A., Balestrieri G., and Shoenfeld Y. Anticardiolipin and anti-beta-2- glycoprotein I antibodies. Autoimmunity 38 (2005) 33-38
64. Liu X., Stocker B.L., and Seeberger P.H. Total synthesis of phosphatidylinositol mannosides of Mycobacterium tuberculosis. J. Am. Chem. Soc. 128 (2006) 3638-3648
65. Ali A., Gowda D.C., and Vishwakarma R.A. A new approach to construct full-length glycosylphosphatidylinositols of parasitic protozoa and [4-deoxy-Man-III]-GPI analogues. Chem. Commun. (Camb.) (2005) 519-521
66. Azzouz N., Rauscher B., Gerold P., Cesbron-Delauw M.F., Dubremetz J.F., and Schwarz R.T. Evidence for de novo sphingolipid biosynthesis in Toxoplasma gondii. Int. J. Parasitol. 32 (2002) 677-684
67. Ejsing C.S., Moehring T., Bahr U., Duchoslav E., Karas M., Simons K., and Shevchenko A. Collision-induced dissociation pathways of yeast sphingolipids and their molecular profiling in total lipid extracts: a study by quadrupole TOF and linear ion traporbitrap mass spectrometry. J. Mass Spectrom. 41 (2006) 372-389
68. Guan X.L., and Wenk M.R. Mass spectrometry-based profiling of phospholipids and sphingolipids in extracts from Saccharomyces cerevisiae. Yeast 23 (2006) 465-477
69. Ralph S.A., van Dooren G.G., Waller R.F., Crawford M.J., Fraunholz M.J., Foth B.J., Tonkin C.J., Roos D.S., and McFadden G.I. Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast. Nat. Rev. Microbiol. 2 (2004) 203-216
70. Patnaik P.K., Field M.C., Menon A.K., Cross G.A., Yee M.C., and Butikofer P. Molecular species analysis of phospholipids from Trypanosoma brucei bloodstream and procyclic forms. Mol. Biochem. Parasitol. 58 (1993) 97-105
71. Morris-Natschke S.L., Ishaq K.S., and Kucera L.S. Phospholipid analogs against HIV-1 infection and disease. Curr. Pharm. Des. 9 (2003) 1441-1451
72. Stief T.W. Singlet oxygen (1O(2))-oxidazable lipids in the HIV membrane, new targets for AIDS therapy?. Med. Hypotheses 60 (2003) 575-577
73. Geisel R.E., Sakamoto K., Russell D.G., and Rhoades E.R. In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guerin is due principally to trehalose mycolates. J. Immunol. 174 (2005) 5007-5015
74. Moody D.B., Ulrichs T., Muhlecker W., Young D.C., Gurcha S.S., Grant E., Rosat J.P., Brenner M.B., Costello C.E., Besra G.S., and Porcelli S.A. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 404 (2000) 884-888
75. Reed M.B., Domenech P., Manca C., Su H., Barczak A.K., Kreiswirth B.N., Kaplan G., and Barry Jr. C.E. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431 (2004) 84-87
76. Gilleron M., Stenger S., Mazorra Z., Wittke F., Mariotti S., Bohmer G., Prandi J., Mori L., Puzo G., and De L.G. Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J. Exp. Med. 199 (2004) 649-659
77. Wang Y., Holmes E., Nicholson J.K., Cloarec O., Chollet J., Tanner M., Singer B.H., and Utzinger J. Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc. Natl. Acad. Sci. USA 101 (2004) 12676-12681
78. Munoz-Elias E.J., and McKinney J.D. Carbon metabolism of intracellular bacteria. Cell Microbiol. 8 (2006) 10-22
79. Boshoff H.I., and Barry III C.E. Tuberculosis - metabolism and respiration in the absence of growth. Nat. Rev. Microbiol. 3 (2005) 70-80
80. Lee R.E., Brennan P.J., and Besra G.S. Mycobacterium tuberculosis cell envelope. Curr. Top. Microbiol. Immunol. 215 (1996) 1-27
81. Nguyen L., Chinnapapagari S., and Thompson C.J. FbpA-dependent biosynthesis of trehalose dimycolate is required for the intrinsic multidrug resistance, cell wall structure, and colonial morphology of Mycobacterium smegmatis. J. Bacteriol. 187 (2005) 6603-6611
82. Deb C., Daniel J., Sirakova T.D., Abomoelak B., Dubey V.S., and Kolattukudy P.E. A novel lipase belonging to the hormone-sensitive lipase family induced under starvation to utilize stored triacylglycerol in Mycobacterium tuberculosis. J. Biol. Chem. 281 (2006) 3866-3875
83. Kremer L., de C.C., Dobson G., Gibson K.J., Bifani P., Balor S., Gorvel J.P., Locht C., Minnikin D.E., and Besra G.S. Identification and structural characterization of an unusual mycobacterial monomeromycolyl-diacylglycerol. Mol. Microbiol. 57 (2005) 1113-1126
84. Alvarez H.M., and Steinbuchel A. Triacylglycerols in prokaryotic microorganisms. Appl. Microbiol. Biotechnol. 60 (2002) 367-376
85. Gupta N., Zahn M.M., Coppens I., Joiner K.A., and Voelker D.R. Selective disruption of phosphatidylcholine metabolism of the intracellular parasite Toxoplasma gondii arrests its growth. J. Biol. Chem. 280 (2005) 16345-16353
86. van Genderen I., Brandimarti R., Torrisi M.R., Campadelli G., and van Meer G. The phospholipid composition of extracellular herpes simplex virions differs from that of host cell nuclei. Virology 200 (1994) 831-836
87. Wang J.K., Kiyokawa E., Verdin E., and Trono D. The Nef protein of HIV-1 associates with rafts and primes T cells for activation. Proc. Natl. Acad. Sci. USA 97 (2000) 394-399
88. Campbell S.M., Crowe S.M., and Mak J. Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. Aids 16 (2002) 2253-2261
89. Graham D.R., Chertova E., Hilburn J.M., Arthur L.O., and Hildreth J.E. Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion associated lipid rafts. J. Virol. 77 (2003) 8237-8248
90. Coil D.A., and Miller A.D. Enhancement of enveloped virus entry by phosphatidylserine. J. Virol. 79 (2005) 11496-11500
91. Callahan M.K., Popernack P.M., Tsutsui S., Truong L., Schlegel R.A., and Henderson A.J. Phosphatidylserine on HIV envelope is a cofactor for infection of monocytic cells. J. Immunol. 170 (2003) 4840-4845
92. Kang P.B., Azad A.K., Torrelles J.B., Kaufman T.M., Beharka A., Tibesar E., DesJardin L.E., and Schlesinger L.S. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J. Exp. Med. 202 (2005) 987-999
93. Long D., Berson J.F., Cook D.G., and Doms R.W. Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide. J. Virol. 68 (1994) 5890-5898
94. Finnegan C.M., Rawat S.S., Puri A., Wang J.M., Ruscetti F.W., and Blumenthal R. Ceramide, a target for antiretroviral therapy. Proc. Natl. Acad. Sci. USA 101 (2004) 15452-15457
95. Rawat S.S., Gallo S.A., Eaton J., Martin T.D., Ablan S., KewalRamani V.N., Wang J.M., Blumenthal R., and Puri A. Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion. J. Virol. 78 (2004) 7360-7368
96. Darveau R.P., Pham T.T., Lemley K., Reife R.A., Bainbridge B.W., Coats S.R., Howald W.N., Way S.S., and Hajjar A.M. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect. Immun. 72 (2004) 5041-5051
97. Pelkmans L., Fava E., Grabner H., Hannus M., Habermann B., Krausz E., and Zerial M. Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 436 (2005) 78-86
98. Lee C.J., Liao C.L., and Lin Y.L. Flavivirus activates phosphatidylinositol 3-kinase signaling to block caspase-dependent apoptotic cell death at the early stage of virus infection. J. Virol. 79 (2005) 8388-8399
99. Hug P., Lin H.M., Korte T., Xiao X., Dimitrov D.S., Wang J.M., Puri A., and Blumenthal R. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5. J. Virol. 74 (2000) 6377-6385
100. Puri A., Hug P., Jernigan K., Barchi J., Kim H.Y., Hamilton J., Wiels J., Murray G.J., Brady R.O., and Blumenthal R. The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA 95 (1998) 14435-14440
101. Liao Z., Cimakasky L.M., Hampton R., Nguyen D.H., and Hildreth J.E. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res. Hum. Retroviruses 17 (2001) 1009-1019
102. Kielian M.C., Keranen S., Kaariainen L., and Helenius A. Membrane fusion mutants of Semliki Forest virus. J. Cell Biol. 98 (1984) 139-145
103. Gatfield J., and Pieters J. Essential role for cholesterol in entry of mycobacteria into macrophages. Science 288 (2000) 1647-1650
104. Ye J., Wang C., Sumpter Jr. R., Brown M.S., Goldstein J.L., and Gale Jr. M. Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation. Proc. Natl. Acad. Sci. USA 100 (2003) 15865-15870
105. O'Riordan M., Moors M.A., and Portnoy D.A. Listeria intracellular growth and virulence require host-derived lipoic acid. Science 302 (2003) 462-464
106. Geisel R.E., Sakamoto K., Russell D.G., and Rhoades E.R. In vivo activity of released cell wall lipids of Mycobacterium bovis Bacillus Calmette-Guerin is due principally to trehalose mycolates. J. Immunol. 174 (2005) 5007-5015
107. Waller R.F., Keeling P.J., Donald R.G., Striepen B., Handman E., Lang-Unnasch N., Cowman A.F., Besra G.S., Roos D.S., and McFadden G.I. Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 95 (1998) 12352-12357
108. Nawabi P., Lykidis A., Ji D., and Haldar K. Neutral-lipid analysis reveals elevation of acylglycerols and lack of cholesterol esters in Plasmodium falciparum-infected erythrocytes. Eukaryot. Cell 2 (2003) 1128-1131
109. Vielemeyer O., McIntosh M.T., Joiner K.A., and Coppens I. Neutral lipid synthesis and storage in the intraerythrocytic stages of Plasmodium falciparum. Mol. Biochem. Parasitol. 135 (2004) 197-209
110. Palacpac N.M., Hiramine Y., Seto S., Hiramatsu R., Horii T., and Mitamura T. Evidence that Plasmodium falciparum diacylglycerol acyltransferase is essential for intraerythrocytic proliferation. Biochem. Biophys. Res. Commun. 321 (2004) 1062-1068
111. Kuge O., Akamatsu Y., and Nishijima M. Abortive infection with Sindbis virus of a Chinese hamster ovary cell mutant defective in phosphatidylserine and phosphatidylethanolamine biosynthesis. Biochim. Biophys. Acta 986 (1989) 61-69
112. Marcus S.L., Wenk M.R., Steele-Mortimer O., and Finlay B.B. A synaptojaninhomologous region of Salmonella typhimurium SigD is essential for inositol phosphatase activity and Akt activation. FEBS Lett. 494 (2001) 201-207
113. Fischer K., Chatterjee D., Torrelles J., Brennan P.J., Kaufmann S.H., and Schaible U.E. Mycobacterial lysocardiolipin is exported from phagosomes upon cleavage of cardiolipin by a macrophage-derived lysosomal phospholipase A2. J. Immunol. 167 (2001) 2187-2192
114. Fratti R.A., Chua J., Vergne I., and Deretic V. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc. Natl. Acad. Sci. USA 100 (2003) 5437-5442
115. Vergne I., Chua J., Lee H.H., Lucas M., Belisle J., and Deretic V. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 102 (2005) 4033-4038
116. Simoes A.P., Fiebig S., Wunderlich F., Vial H., Roelofsen B., and op den Kamp J.A. Plasmodium chabaudi-parasitized erythrocytes: phosphatidylcholine species of parasites and host cell membranes. Mol. Biochem. Parasitol. 57 (1993) 345-348
117. Vial H.J., Wein S., Farenc C., Kocken C., Nicolas O., Ancelin M.L., Bressolle F., Thomas A., and Calas M. Prodrugs of bisthiazolium salts are orally potent antimalarials. Proc. Natl. Acad. Sci. USA 101 (2004) 15458-15463
118. Thompson C.R., Iyer S.S., Melrose N., VanOosten R., Johnson K., Pitson S.M., Obeid L.M., and Kusner D.J. Sphingosine kinase 1 (SK1) is recruited to nascent phagosomes in human macrophages: inhibition of SK1 translocation by Mycobacterium tuberculosis. J. Immunol. 174 (2005) 3551-3561
119. Sonda S., Sala G., Ghidoni R., Hemphill A., and Pieters J. Inhibitory effect of aureobasidin A on Toxoplasma gondii. Antimicrob. Agents Chemother. 49 (2005) 1794-1801
120. Lauer S.A., Chatterjee S., and Haldar K. Uptake and hydrolysis of sphingomyelin analogues in Plasmodium falciparum-infected red cells. Mol. Biochem. Parasitol. 115 (2001) 275-281
121. Sonda S., Ting L.M., Novak S., Kim K., Maher J.J., Farese Jr. R.V., and Ernst J.D. Cholesterol esterification by host and parasite is essential for optimal proliferation of Toxoplasma gondii. J. Biol. Chem. 276 (2001) 34434-34440
122. Nishikawa Y., Quittnat F., Stedman T.T., Voelker D.R., Choi J.Y., Zahn M., Yang M., Pypaert M., Joiner K.A., and Coppens I. Host cell lipids control cholesteryl ester synthesis and storage in intracellular Toxoplasma. Cell Microbiol. 7 (2005) 849-867
123. Jomaa H., Wiesner J., Sanderbrand S., Altincicek B., Weidemeyer C., Hintz M., Turbachova I., Eberl M., Zeidler J., Lichtenthaler H.K., Soldati D., and Beck E. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 285 (1999) 1573-1576
124. Ling Y., Sahota G., Odeh S., Chan J.M., Araujo F.G., Moreno S.N., and Oldfield E. Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations. J. Med. Chem. 48 (2005) 3130-3140
125. Eastman R.T., Buckner F.S., Yokoyama K., Gelb M.H., and Van Voorhis W.C. Thematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylation. J. Lipid Res. 47 (2006) 233-240
126. Lindwasser O.W., and Resh M.D. Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding. Proc. Natl. Acad. Sci. USA 99 (2002) 13037-13042
127. Resh M.D. Intracellular trafficking of HIV-1 Gag: how Gag interacts with cell membranes and makes viral particles. AIDS Rev. 7 (2005) 84-91
128. Cluett E.B., Kuismanen E., and Machamer C.E. Heterogeneous distribution of the unusual phospholipid semilysobisphosphatidic acid through the Golgi complex. Mol. Biol. Cell 8 (1997) 2233-2240
129. Campbell S., Fisher R.J., Towler E.M., Fox S., Issaq H.J., Wolfe T., Phillips L.R., and Rein A. Modulation of HIV-like particle assembly in vitro by inositol phosphates. Proc. Natl. Acad. Sci. USA 98 (2001) 10875-10879
130. Ono A., Ablan S.D., Lockett S.J., Nagashima K., and Freed E.O. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl. Acad. Sci. USA 101 (2004) 14889-14894
131. Baek S.H., Kwak J.Y., Lee S.H., Lee T., Ryu S.H., Uhlinger D.J., and Lambeth J.D. Lipase activities of p37, the major envelope protein of vaccinia virus. J. Biol. Chem. 272 (1997) 32042-32049
132. De Libero G., and Mori L. Recognition of lipid antigens by T cells. Nat. Rev. Immunol. 5 (2005) 485-496
133. Winau F., Schwierzeck V., Hurwitz R., Remmel N., Sieling P.A., Modlin R.L., Porcelli S.A., Brinkmann V., Sugita M., Sandhoff K., Kaufmann S.H., and Schaible U.E. Saposin C is required for lipid presentation by human CD1b. Nat. Immunol. 5 (2004) 169-174
134. Zheng Y.H., Plemenitas A., Fielding C.J., and Peterlin B.M. Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions. Proc. Natl. Acad. Sci. USA 100 (2003) 8460-8465
135. Nguyen D.H., and Hildreth J.E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 74 (2000) 3264-3272
136. Ono A., and Freed E.O. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. USA 98 (2001) 13925-13930
137. Scheiffele P., Rietveld A., Wilk T., and Simons K. Influenza viruses select ordered lipid domains during budding from the plasma membrane. J. Biol. Chem. 274 (1999) 2038-2044